Fig. 6: RNF157-AS1 overexpression indicated a favorable prognosis for EOC patients based on GEO and TCGA databases. | Cell Death & Disease

Fig. 6: RNF157-AS1 overexpression indicated a favorable prognosis for EOC patients based on GEO and TCGA databases.

From: Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy

Fig. 6

According Kaplan–Meier Plotter, EOC patients in the GEO database (including GSE18520, GSE19829, GSE26193, GSE27651, GSE30161, GSE63885, and GSE9891) with high expression of RNF157-AS1 had a good prognosis for OS (A) and PPS (C) prognoses, but not a good for PFS prognosis (B) compared with those patients with low expression of RNF157-AS1. Based on TCGA database analysis, EOC patients with high RNF157-AS1 exhibited increased OS (D) and PPS (F) time compared with patients with low levels of RNF157-AS1 expression. However, RNF157-AS1 expression had no effect on the PFS (E) time.

Back to article page